Danila Valmori
Division of Clinical Onco-Immunology
Ludwig Institute for Cancer Research
University Hospital
CHUV, Lausanne
Switzerland
Name/email consistency: high
- Vaccination with a Melan-A peptide selects an oligoclonal T cell population with increased functional avidity and tumor reactivity. Valmori, D., Dutoit, V., Schnuriger, V., Quiquerez, A.L., Pittet, M.J., Guillaume, P., Rubio-Godoy, V., Walker, P.R., Rimoldi, D., Liénard, D., Cerottini, J.C., Romero, P., Dietrich, P.Y. J. Immunol. (2002)
- Induction of potent antitumor CTL responses by recombinant vaccinia encoding a melan-A peptide analogue. Valmori, D., Lévy, F., Miconnet, I., Zajac, P., Spagnoli, G.C., Rimoldi, D., Liénard, D., Cerundolo, V., Cerottini, J.C., Romero, P. J. Immunol. (2000)
- Tetramer-guided analysis of TCR beta-chain usage reveals a large repertoire of melan-A-specific CD8+ T cells in melanoma patients. Valmori, D., Dutoit, V., Liénard, D., Lejeune, F., Speiser, D., Rimoldi, D., Cerundolo, V., Dietrich, P.Y., Cerottini, J.C., Romero, P. J. Immunol. (2000)
- Naturally occurring human lymphocyte antigen-A2 restricted CD8+ T-cell response to the cancer testis antigen NY-ESO-1 in melanoma patients. Valmori, D., Dutoit, V., Liénard, D., Rimoldi, D., Pittet, M.J., Champagne, P., Ellefsen, K., Sahin, U., Speiser, D., Lejeune, F., Cerottini, J.C., Romero, P. Cancer Res. (2000)
- An antigen-targeted approach to adoptive transfer therapy of cancer. Valmori, D., Pittet, M.J., Rimoldi, D., Liénard, D., Dunbar, R., Cerundolo, V., Lejeune, F., Cerottini, J.C., Romero, P. Cancer Res. (1999)
- Analysis of the cytolytic T lymphocyte response of melanoma patients to the naturally HLA-A*0201-associated tyrosinase peptide 368-376. Valmori, D., Pittet, M.J., Vonarbourg, C., Rimoldi, D., Liénard, D., Speiser, D., Dunbar, R., Cerundolo, V., Cerottini, J.C., Romero, P. Cancer Res. (1999)
